Corporate reputation management in the US pharmaceutical industry

Goldstein, Kimberly and Doorley, John and Turner, Paul (2011) Corporate reputation management in the US pharmaceutical industry.

Full text not available from this repository.

Abstract

The reputations of firms may be linked to the degree to which they have formal reputation management programs. To examine that hypothesis the authors surveyed firms in the U.S. pharmaceutical industry where reputation is a highly visible challenge. We compared the reputation measurement and management efforts of the most admired firms with those of less admired firms. The data indicate a positive correlation in five areas – that is, between reputation and having an ongoing reputation measurement program; having an active reputation management program; having a formal reputation management plan; having an individual or unit charged with responsibility for coordinating / overseeing reputation management; and having the chief communication officer as a member of the company‘s executive committee.

Item Type: Journal Article
Additional Information: Citation: Goldstein, K., Doorley, J. and Turner, P., 2011. Corporate reputation management in the US pharmaceutical industry. Gainesville, FL: Institute for Public Relations..
Faculty: Lord Ashcroft International Business School
Depositing User: Mr I Walker
Date Deposited: 26 May 2011 10:59
Last Modified: 07 Jul 2016 12:49
URI: http://arro.anglia.ac.uk/id/eprint/132135

Actions (login required)

Edit Item Edit Item